JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

April 2024

Change Notification No. 05 - 2024

  • Chapter 21 - Tissue banking: tissue retrieval and processing
  • Chapter 7 - Requirements for the timing of testing for Hematopoietic Progenitor Cells (HPCs)

March 2024

Change Notification No. 03 - 2024

  • Chapter 2 - Quality in blood and tissue establishments and hospital blood banks
  • Chapter 6 - Evaluation and manufacture of blood components
  • Chapter 7 - Specifications for blood components
  • Annexe 3 - Provisional Components
  • Annexe 4 - Redundant Components
  • Annexe 5 - Blood Components for Contingency Use

December 2023

Change Notification No. 40 - 2023

November 2023

Change Notification No. 39 - 2023

  • Annexe 7 - Requirements for the timing of testing for HPCs

September 2023

Change Notification No. 16 - 2023

  • Chapter 4 - Premises and quality assurance at blood donor sessions
  • Chapter 5 - Collection of a blood or component donation
  • Chapter 11 - Reagent manufacture
  • Chapter 12 - Donation testing (red cell immunohaematology)
  • Chapter 13 - Patient testing (red cell immunohaematology)
  • Chapter 14 - Guidelines for the use of DNA/PCR techniques in Blood Establishments
  • Chapter 15 - Molecular typing for red cell antigens
  • Chapter 16 - HLA typing and HLA serology
  • Chapter 17 - Granulocyte immunology
  • Chapter 18 - Platelet immunology
  • Chapter 22 - Haemopoietic progenitor cells
  • Annexe 7 - Requirements for the timing of testing for HPCs

April 2023

Change Notification No. 22 - 2023

February 2023

Change Notification No. 06 - 2023

  • Chapter 9 - Microbiology tests for donors and donations: general specifications for laboratory test procedures
  • Chapter 10 - Investigation of suspected transfusion-transmitted infection
  • Chapter 19 - Tissue Banking: general principles
  • Chapter 20 - Tissue Banking: selection of donors
  • Chapter 21 - Tissue Banking: tissue retrieval and processing
  • Annexe 6 - Advanced Therapy Medicinal Products (ATMPs)

June 2022

Change Notification No. 33 - 2022

  • Chapter 8 - Evaluation of novel blood components, production processes and blood packs: generic protocols

March 2022

Change Notification No. 09 - 2022

  • Chapter 7 - Human Plasma for Fractionation Leucocyte Depleted

February 2022

Change Notification No. 10 - 2022

  • Annexe 4 - Redundant Components: Convalescent Plasma

Change Notification No. 11 - 2022

  • Annexe 3 - Provisional Components: Whole blood, leucocyte depleted, for clinical studies

Change Notification No. 12 - 2022

  • Annexe 3 - Provisional Components: Cryoprecipitate pooled, leucocyte depleted, extended shelf life post-thaw

January 2022

Change Notification No. 44 - 2021

  • Annexe 5 - Blood Components for Contingency Use

June 2021

Change Notification No.18 - 2021

  • Chapter 3 - Care and selection of whole blood and component donors (including donors of pre-deposit autologous blood)

January 2021

Change Notification No. 03 - 2021

  • Chapter 21 - Tissue banking: tissue retrieval and processing

November 2020

Change Notification No. 66 - 2020

  • Annexe 3 - Provisional Component: Convalescent Plasma (COVID-19), FFP, Leucocyte Depleted

Change Notification No. 67 - 2020

  • Annexe 3 - Provisional Component: Convalescent Plasma (COVID-19), FFP, for Neonates and Infants, Leucocyte Depleted

October 2020

Change Notification No. 35 - 2020

  • Annexe 3 - Provisional Component: Whole Blood, Leucocyte Depleted for Clinical Studies

August 2020

Change Notification No. 47 - 2020

  • Annexe 5 - Platelets, Apheresis, Leucocyte Depleted, at Reduced Dose as a Contingency

June 2020

Change Notification No. 32 - 2020

  • Annexe 3 - Provisional Component: Red Cells and Plasma, Leucocyte Depleted

May 2020

Change Notification No. 23 - 2020

  • Chapter 7 - Fresh Frozen Plasma for Neonates and Infants, Leucocyte Depleted

Change Notification No. 24 - 2020

  • Chapter 7 - Cryoprecipitate for Neonates and Infants, Leucocyte Depleted

Change Notification No. 25 - 2020

  • Chapter 7 - Fresh Frozen Plasma, Leucocyte Depleted

Change Notification No. 27 - 2020

April 2020

Change Notification No. 19 - 2020

Change Notification No. 20 - 2020

Change Notification No. 21 - 2020

  • Annexe 5 - Blood Components for Contingency Use

Change Notification No. 22 - 2020

  • Annexe 5.1 - Red Cells in Additive Solution, Leucocyte Depleted, Extended Shelf Life

November 2019

Change Notification No. 34 - 2019

  • Chapter 7 - Platelets in Plasma and Additive Solution for Neonatal Use, Leucocyte Depleted

April 2017

Change Notification No. 10 - 2017

  • Chapter 7 - Use of plasma from first time donors

January 2017

Change Notification No. 01 - 2017

  • Chapter 11 - General guidelines for reagent red cell manufacture

Change Notification No. 02 - 2017

August 2016

Change Notification No. 32 - 2016

  • Chapter 7 - Red Cells, Thawed and Washed, Leucocyte Depleted

Change Notification No. 33 - 2016

  • Chapter 7 - Removal of red cells from a controlled temperature environment

Change Notification No. 34 - 2016

  • Chapter 7 - Removal of upper limit of pH from Platelet Components

June 2016

Change Notification No. 31 - 2016

May 2016

Change Notification No. 23 - 2016

  • Chapter 21 - Tissue banking: Tissue retrieval and processing

April 2016

Change Notification No. 16 - 2016

  • Chapter 7 - Fresh Frozen Plasma, Leucocyte Depleted

January 2016

Change Notification No. 12 - 2016

  • Chapter 9 - Microbiology tests for donors and donations: general specifications for laboratory test procedures

December 2015

Change Notification No. 18 - 2015

  • Chapter 7 - Interruptions to agitation and testing of Platelets, Pooled, Buffy Coat Derived, Leucocyte Depleted and Platelets, Apheresis, Leucocyte Depleted

Change Notification No. 19 - 2015

  • Chapter 7 - Platelets in Additive Solution and Plasma, Leucocyte Depleted

Change Notification No. 20 - 2015

  • Chapter 6 - Specific gravity of blood components

Change Notification No. 21 - 2015

  • Chapter 7 - Leucocyte depletion of blood components - Concessionary release

Change Notification No. 22 - 2015

  • Chapter 7 - Concessionary Release Limits for Selected Components

Change Notification No. 23 - 2015

  • Chapter 9 - Removal of Chapter 9.4.2. and Figure 9.6 in Chapter 9

Change Notification No. 29 - 2015

  • Chapter 25.6 - Table 25.5: Protocol 000001 – blood component dispatch information

Change Notification No. 30 - 2015

  • Chapter 7 - Red Cells, Washed, Leucocyte Depleted

January 2015

Change Notification No. 01 - 2015

  • Chapter 25.6 - Tables 25.4 and 25.5: Protocol 000001 – blood component dispatch information

June 2014

Change Notification No. 25 - 2014

January 2014

Change Notification No. 15 - 2013

  • Chapter 3 - Appendix I: Extra-corporeal volume tables

Change Notification No. 16 - 2013

Errata - Amended pages

  • Chapter 7.9.1 - Platelets, Pooled, Buffy Coat Derived, Leucocyte Depleted
  • Chapter 7.11.1 - Platelets in Additive Solution and Plasma, Leucocyte Depleted
  • Chapter 9.5.3.1 - Single-test system
  • Chapter 12.11.2 - Blood and blood components from group O donors with high titres of anti-A, anti-B and/or anti-A,B
  • Chapter 7.12.1 - Platelets in Additive Solution, Leucocyte Depleted

Change Notification No. 17 - 2013

Shelf-life (when frozen) of FFP, cryoprecipitate, cryodepleted plasma and MB-treated FFP

  • Chapter 7.15 - Fresh Frozen Plasma, Leucocyte Depleted
  • Chapter 7.16 - Fresh Frozen Plasma, Methylene Blue Treated and Removed, Leucocyte Depleted
  • Chapter 7.17 - Cryoprecipitate, Leucocyte Depleted
  • Chapter 7.18 - Cryoprecipitate Pooled, Leucocyte Depleted
  • Chapter 7.20 - Plasma, Cryoprecipitate Depleted, Leucocyte Depleted
  • Chapter 7.27 - Fresh Frozen Plasma, Neonatal Use, Methylene Blue Treated and Removed, Leucocyte Depleted
  • Chapter 7.28 - Cryoprecipitate, Methylene Blue Treated and Removed, Leucocyte Depleted
  • Chapter 7.33 - Cryoprecipitate, Pooled, Methylene Blue Treated and Removed, Leucocyte Depleted

June 2013

Change Notification No. 11 - 2013

  • Chapter 7.33 - Cryoprecipitate, Pooled, Methylene Blue Treated and Removed, Leucocyte Depleted

Change Notification No. 12 - 2013

  • Annexe 3 - Platelets in Additive Solution and Plasma, Leucocyte Depleted, Pathogen-reduced

 

Last updated 18/04/2024